Press Releases

Oct 21, 2020
Bicycle Therapeutics Announces Expansion of Scientific Advisory Board
- Four renowned experts join to advise Bicycle as the company advances pipeline of novel cancer therapeutic candidates CAMBRIDGE, England & BOSTON --(BUSINESS WIRE)--Oct. 21, 2020-- Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new and differentiated class of
Sep 03, 2020
Bicycle Therapeutics to Participate in Upcoming Virtual Investor Conferences
CAMBRIDGE, England & BOSTON --(BUSINESS WIRE)--Sep. 3, 2020-- Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle ®) technology, today announced that management will
Aug 11, 2020
Bicycle Therapeutics Appoints Dr. Dominic Smethurst as Chief Medical Officer
CAMBRIDGE, England & BOSTON --(BUSINESS WIRE)--Aug. 11, 2020-- Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle ® ) technology, today announced the appointment of Dominic
Displaying 1 - 10 of 26